Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$7.80 USD
+0.88 (12.72%)
Updated Sep 29, 2023 04:00 PM ET
After-Market: $7.74 -0.06 (-0.77%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
EDIT 7.80 +0.88(12.72%)
Will EDIT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EDIT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EDIT
Ultragenyx (RARE) Soars 6.1%: Is Further Upside Left in the Stock?
Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Editas (EDIT) Down 4.3% Since Last Earnings Report?
Editas' (EDIT) Q2 Earnings Beat, Sales Miss, Pipeline in Focus
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
Other News for EDIT
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
What You Missed On Wall Street This Morning
Wall Street Lunch: The Issue Of Inflation
Biggest stock movers today: Walgreens Boots Alliance, Nike, Editas Medicine and more
Expert Ratings for Editas Medicine